Bioventure firms struggling to explore overseas markets

Published: 2002-10-08 06:59:00

Updated: 2002-10-08 06:59:00

The domestic bioventure firms, which have recently experienced serious setbacks, are endeavoring to explore overseas markets with concerted efforts of their normalized business operations.

They have selected more large areas with big marketability, such as US, Russia, Japan and China.

Neoph...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK